$MHO
M/I HOMES, INC. Stock $mho

$mho Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000079929223000048 Filed on April 28, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$1.014B	$1.001B
YoY Change	-2.56%	16.23%
Cost Of Revenue	$755.8M	$765.9M
YoY Change	-0.07%	18.25%
Gross Profit	$258.2M	$234.6M
YoY Change	-9.18%	10.1%
Gross Profit Margin	25.46%	23.45%
Selling, General & Admin	$107.5M	$100.0M
YoY Change	6.02%	10.9%
% of Gross Profit	41.65%	42.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.597M	$3.214M
YoY Change	-1.21%	-0.92%
% of Gross Profit	1.39%	1.37%
Operating Expenses	$107.5M	$100.0M
YoY Change	6.02%	10.9%
Operating Profit	$150.7M	$134.6M
YoY Change	-17.61%	9.5%
Interest Expense	$4.698M	$1.396M
YoY Change	577.92%	108.05%
% of Operating Profit	3.12%	1.04%
Other Income/Expense, Net
YoY Change
Pretax Income	$155.4M	$136.0M
YoY Change	-14.72%	11.23%
Income Tax	$37.36M	$32.90M
% Of Pretax Income	24.05%	24.19%
Net Earnings	$118.0M	$103.1M
YoY Change	-13.77%	12.22%
Net Earnings / Revenue	11.64%	10.3%
Basic Earnings Per Share	$4.25	$3.73
Diluted Earnings Per Share	$4.12	$3.64
COMMON SHARES
Basic Shares Outstanding	27.83M shares	27.67M shares
Diluted Shares Outstanding	28.62M shares	28.31M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$668.3M	$542.6M
YoY Change	254.05%	148.19%
Cash & Equivalents	$668.3M	$542.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$2.687B	$2.657B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.355B	$3.200B
YoY Change	11.66%	14.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$93.90M	$37.42M
YoY Change	159.75%	1.75%
Goodwill	$16.40M	$16.40M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$41.99M	$49.03M
YoY Change	-24.52%	-14.44%
Other Assets	$208.9M	$244.6M
YoY Change	2.03%	16.11%
Total Long-Term Assets	$506.4M	$562.4M
YoY Change	3.72%	11.29%
TOTAL ASSETS
Total Short-Term Assets	$3.355B	$3.200B
Total Long-Term Assets	$506.4M	$562.4M
Total Assets	$3.862B	$3.762B
YoY Change	10.55%	13.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$264.7M	$208.4M
YoY Change	-19.65%	-25.93%
Accrued Expenses	$59.46M	$60.76M
YoY Change	12.07%	17.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$422.2M	$367.0M
YoY Change	-18.53%	-21.01%
LONG-TERM LIABILITIES
Long-Term Debt	$879.5M	$916.4M
YoY Change	-0.89%	2.16%
Other Long-Term Liabilities	$261.6M	$295.8M
YoY Change	-2.9%	22.63%
Total Long-Term Liabilities	$1.141B	$1.212B
YoY Change	-1.36%	6.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$422.2M	$367.0M
Total Long-Term Liabilities	$1.141B	$1.212B
Total Liabilities	$1.563B	$1.579B
YoY Change	-6.67%	-1.48%
SHAREHOLDERS EQUITY
Retained Earnings	$2.057B	$1.939B
YoY Change	30.69%	34.92%
Common Stock	$350.4M	$350.3M
YoY Change	0.63%	1.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$109.0M	$106.1M
YoY Change	4.87%	32.55%
Treasury Stock Shares
Shareholders Equity	$2.298B	$2.183B
YoY Change
Total Liabilities & Shareholders Equity	$3.862B	$3.762B
YoY Change	10.55%	13.79%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$118.0M	$103.1M
YoY Change	-13.77%	12.22%
Depreciation, Depletion And Amortization	$3.597M	$3.214M
YoY Change	-1.21%	-0.92%
Cash From Operating Activities	$166.2M	$251.5M
YoY Change	1703.67%	262.78%
INVESTING ACTIVITIES
Capital Expenditures	$43.00K	$2.079M
YoY Change	-102.89%	72.53%
Acquisitions
YoY Change
Other Investing Activities	$2.034M	-$2.714M
YoY Change	-160.88%	-50.01%
Cash From Investing Activities	$1.991M	-$4.793M
YoY Change	-141.23%	-27.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-42.46M	-$15.68M
YoY Change	24.02%	-80.51%
NET CHANGE
Cash From Operating Activities	166.2M	$251.5M
Cash From Investing Activities	1.991M	-$4.793M
Cash From Financing Activities	-42.46M	-$15.68M
Net Change In Cash	125.7M	$231.0M
YoY Change	-521.17%	-1400.65%
FREE CASH FLOW
Cash From Operating Activities	$166.2M	$251.5M
Capital Expenditures	$43.00K	$2.079M
Free Cash Flow	$166.1M	$249.4M
YoY Change	1452.49%	266.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000799292
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	58000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	58000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30137141	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30137141	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2421525	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2697058	shares
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16000	usd
CY2023Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2022Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1200000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1200000	usd
CY2023Q1	mho	Homebuildingoperationspercentoftotalrevenue Homebuildingoperationspercentoftotalrevenue	0.97	rate
CY2022Q1	mho	Homebuildingoperationspercentoftotalrevenue Homebuildingoperationspercentoftotalrevenue	0.97	rate
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-12434
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	M/I HOMES, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-1210837
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4131 Worth Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbus
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43219
CY2023Q1	dei	City Area Code CityAreaCode	614
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	418-8000
CY2023Q1	dei	Security12b Title Security12bTitle	Common Shares, par value $.01
CY2023Q1	dei	Trading Symbol TradingSymbol	MHO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27829416	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	542564000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	311542000	usd
CY2023Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	226629000	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	242539000	usd
CY2023Q1	us-gaap	Inventory Real Estate InventoryRealEstate	2657409000	usd
CY2022Q4	us-gaap	Inventory Real Estate InventoryRealEstate	2828602000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37419000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37446000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	49031000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	51554000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59787000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60416000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18019000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18019000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	16400000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	16400000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	155112000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	148405000	usd
CY2023Q1	us-gaap	Assets Assets	3762370000	usd
CY2022Q4	us-gaap	Assets Assets	3714923000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	208426000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	228597000	usd
CY2023Q1	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	97800000	usd
CY2022Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	93118000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	60763000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	61310000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	249055000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	276217000	usd
CY2023Q1	us-gaap	Special Assessment Bond Noncurrent SpecialAssessmentBondNoncurrent	27060000	usd
CY2022Q4	us-gaap	Special Assessment Bond Noncurrent SpecialAssessmentBondNoncurrent	29701000	usd
CY2023Q1	mho	Obligation For Consolidated Inventory Not Owned ObligationForConsolidatedInventoryNotOwned	19648000	usd
CY2022Q4	mho	Obligation For Consolidated Inventory Not Owned ObligationForConsolidatedInventoryNotOwned	17048000	usd
CY2023Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	223618000	usd
CY2022Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	245741000	usd
CY2023Q1	mho	Seniornotesdue2028 Seniornotesdue2028	396298000	usd
CY2022Q4	mho	Seniornotesdue2028 Seniornotesdue2028	396105000	usd
CY2023Q1	mho	Senior Notes Due2030 SeniorNotesDue2030	296487000	usd
CY2022Q4	mho	Senior Notes Due2030 SeniorNotesDue2030	296361000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1579155000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1644198000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	58000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30137141	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	301000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	301000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	349988000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	352639000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1939049000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1835983000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2421525	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2697058	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	106123000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	118198000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2183215000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2070725000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3762370000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3714923000	usd
CY2023Q1	us-gaap	Revenues Revenues	1000530000	usd
CY2022Q1	us-gaap	Revenues Revenues	860811000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	765904000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	647702000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50960000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48783000	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	49080000	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	41421000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16000	usd
CY2023Q1	mho	Interest Income Net Of Interest Expense InterestIncomeNetOfInterestExpense	1389000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	671000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	864548000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	738561000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	135982000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	122250000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32916000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30411000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	103066000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	91839000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.73
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.23
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.64
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.16
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27602000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28424000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28305000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29072000	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2070725000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	103066000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6439000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2023000	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	962000	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Distribution Paid DeferredCompensationArrangementWithIndividualDistributionPaid	0	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2183215000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1624184000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	91839000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	206000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1831000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	15393000	usd
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	1022000	usd
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Distribution Paid DeferredCompensationArrangementWithIndividualDistributionPaid	0	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1703689000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	103066000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	91839000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	494461000	usd
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	479781000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	514346000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	549025000	usd
CY2023Q1	mho	Fair Value Adjustment Of Mortgage Loans Held For Sale FairValueAdjustmentOfMortgageLoansHeldForSale	-3975000	usd
CY2022Q1	mho	Fair Value Adjustment Of Mortgage Loans Held For Sale FairValueAdjustmentOfMortgageLoansHeldForSale	5956000	usd
CY2023Q1	mho	Additions Of Servicing Asset AdditionsOfServicingAsset	-1390000	usd
CY2022Q1	mho	Additions Of Servicing Asset AdditionsOfServicingAsset	-3583000	usd
CY2023Q1	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	523000	usd
CY2022Q1	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	300000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	3214000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	3244000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	660000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	644000	usd
CY2023Q1	mho	Loss On Sale Of Mortgage Servicing Rights LossOnSaleOfMortgageServicingRights	0	usd
CY2022Q1	mho	Loss On Sale Of Mortgage Servicing Rights LossOnSaleOfMortgageServicingRights	176000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2023000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1831000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-175316000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	129295000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4564000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	25025000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-20171000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	36882000	usd
CY2023Q1	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	4682000	usd
CY2022Q1	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	23818000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-38969000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-31746000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	11206000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	25057000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	251499000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	69326000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2079000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1205000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	2714000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	5429000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4793000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6634000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-22123000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-62510000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-2677000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15393000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	80000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6439000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	206000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15684000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-80454000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	231022000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17762000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	311542000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236368000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	542564000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218606000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6176000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	7895000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	838000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	993000	usd
CY2023Q1	mho	Community Development District Infrastructure CommunityDevelopmentDistrictInfrastructure	-2641000	usd
CY2022Q1	mho	Community Development District Infrastructure CommunityDevelopmentDistrictInfrastructure	-3323000	usd
CY2023Q1	mho	Consolidated Inventory Not Owned Obligation ConsolidatedInventoryNotOwnedObligation	2600000	usd
CY2022Q1	mho	Consolidated Inventory Not Owned Obligation ConsolidatedInventoryNotOwnedObligation	60000	usd
CY2023Q1	mho	Distribution Of Single Family Lots From Unconsolidated Llcs DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs	5244000	usd
CY2022Q1	mho	Distribution Of Single Family Lots From Unconsolidated Llcs DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs	5257000	usd
CY2023Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Unaudited Condensed Consolidated Financial Statements (the “financial statements”) of M/I Homes, Inc. and its subsidiaries (the “Company”) and notes thereto have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. The financial statements include the accounts of the Company. All intercompany transactions have been eliminated. Results for the interim period are not necessarily indicative of results for a full year. In the opinion of management, the accompanying financial statements reflect all adjustments (all of which are normal and recurring in nature) necessary for a fair presentation of financial results for the interim periods presented. These financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that period. Actual results could differ from these estimates and have a significant impact on the financial condition and results of operations and cash flows. With regard to the Company, estimates and assumptions are inherent in calculations relating to valuation of inventory and investment in unconsolidated joint ventures, property and equipment depreciation, valuation of derivative financial instruments, accounts payable on inventory, accruals for costs to complete inventory, accruals for warranty claims, accruals for self-insured general liability claims, litigation, accruals for health care and workers’ compensation, accruals for guaranteed or indemnified loans, stock-based compensation expense, income taxes, and contingencies. Items that could have a significant impact on these estimates and assumptions include the risks and uncertainties listed in “Item 1A. Risk Factors” in Part I of our 2022 Form 10-K, as the same may be updated from time to time in our subsequent filings with the SEC. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our significant accounting policies during the quarter ended March 31, 2023 as compared to those disclosed in our 2022 Form 10-K.</span></div>
CY2023Q1	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1279673000	usd
CY2022Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1294779000	usd
CY2023Q1	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	17959000	usd
CY2022Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	3331000	usd
CY2023Q1	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	1190519000	usd
CY2022Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	1366804000	usd
CY2023Q1	mho	Model Home Accumulated Depreciation ModelHomeAccumulatedDepreciation	10693000	usd
CY2022Q4	mho	Model Home Accumulated Depreciation ModelHomeAccumulatedDepreciation	10371000	usd
CY2023Q1	mho	Inventory Model Homes And Furnishings InventoryModelHomesAndFurnishings	63640000	usd
CY2022Q4	mho	Inventory Model Homes And Furnishings InventoryModelHomesAndFurnishings	61200000	usd
CY2023Q1	mho	Community Development District CommunityDevelopmentDistrict	27060000	usd
CY2022Q4	mho	Community Development District CommunityDevelopmentDistrict	29701000	usd
CY2023Q1	mho	Land Purchase Deposits LandPurchaseDeposits	58910000	usd
CY2022Q4	mho	Land Purchase Deposits LandPurchaseDeposits	55739000	usd
CY2023Q1	us-gaap	Land Under Purchase Options Recorded LandUnderPurchaseOptionsRecorded	19648000	usd
CY2022Q4	us-gaap	Land Under Purchase Options Recorded LandUnderPurchaseOptionsRecorded	17048000	usd
CY2023Q1	us-gaap	Inventory Real Estate InventoryRealEstate	2657409000	usd
CY2022Q4	us-gaap	Inventory Real Estate InventoryRealEstate	2828602000	usd
CY2023Q1	mho	Number Of Speculative Homes NumberOfSpeculativeHomes	1551	homes
CY2023Q1	mho	Speculative Homes Carrying Value SpeculativeHomesCarryingValue	316200000	usd
CY2022Q4	mho	Number Of Speculative Homes NumberOfSpeculativeHomes	1827
CY2022Q4	mho	Speculative Homes Carrying Value SpeculativeHomesCarryingValue	431700000	usd
CY2023Q1	mho	Community Development District CommunityDevelopmentDistrict	27100000	usd
CY2022Q4	mho	Community Development District CommunityDevelopmentDistrict	29700000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	29675000	usd
CY2021Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	24343000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	9024000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	8791000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	8090000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	7327000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	30609000	usd
CY2022Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	25807000	usd
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	7635000	usd
CY2022Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	9462000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	49000000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	51600000	usd
CY2023Q1	mho	Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements	-2600000	usd
CY2023Q1	mho	Distribution Of Single Family Lots From Unconsolidated Llcs DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs	5200000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	2700000	usd
CY2023Q1	mho	Companysinvestmentinjointdevelopmentorsimilaragreements Companysinvestmentinjointdevelopmentorsimilaragreements	43400000	usd
CY2022Q4	mho	Companysinvestmentinjointdevelopmentorsimilaragreements Companysinvestmentinjointdevelopmentorsimilaragreements	45900000	usd
CY2023Q1	mho	Equityinvestedin Ll Cs EquityinvestedinLLCs	5700000	usd
CY2022Q4	mho	Equityinvestedin Ll Cs EquityinvestedinLLCs	5600000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	49000000	usd
CY2023Q1	mho	Loan Repurchase Guarantee Liability LoanRepurchaseGuaranteeLiability	600000	usd
CY2022Q4	mho	Loan Repurchase Guarantee Liability LoanRepurchaseGuaranteeLiability	700000	usd
CY2023Q1	mho	Notional Amount Of Best Effort Contracts And Related Committed Interest Rate Lock Commitments NotionalAmountOfBestEffortContractsAndRelatedCommittedInterestRateLockCommitments	1683000	usd
CY2022Q4	mho	Notional Amount Of Best Effort Contracts And Related Committed Interest Rate Lock Commitments NotionalAmountOfBestEffortContractsAndRelatedCommittedInterestRateLockCommitments	0	usd
CY2023Q1	mho	Notional Amount Of Uncommitted Interest Rate Lock Commitments NotionalAmountOfUncommittedInterestRateLockCommitments	250065000	usd
CY2022Q4	mho	Notional Amount Of Uncommitted Interest Rate Lock Commitments NotionalAmountOfUncommittedInterestRateLockCommitments	262529000	usd
CY2023Q1	mho	Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments	259000000	usd
CY2022Q4	mho	Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments	341088000	usd
CY2023Q1	mho	Best Effort Contracts And Related Mortgage Loans Held For Sale BestEffortContractsAndRelatedMortgageLoansHeldForSale	16576000	usd
CY2022Q4	mho	Best Effort Contracts And Related Mortgage Loans Held For Sale BestEffortContractsAndRelatedMortgageLoansHeldForSale	16507000	usd
CY2023Q1	mho	Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale	212000000	usd
CY2022Q4	mho	Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale	232518000	usd
CY2023Q1	mho	Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities	215420000	usd
CY2022Q4	mho	Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities	233378000	usd
CY2023Q1	mho	Gain Loss On Assets And Liabilities Measured On Recurring Basis GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis	8328000	usd
CY2022Q1	mho	Gain Loss On Assets And Liabilities Measured On Recurring Basis GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis	500000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023Q1	mho	Total Of Loans Covered By Guarantees TotalOfLoansCoveredByGuarantees	493500000	usd
CY2022Q4	mho	Total Of Loans Covered By Guarantees TotalOfLoansCoveredByGuarantees	360400000	usd
CY2023Q1	mho	Total Of Guaranteed Loans Inquired About TotalOfGuaranteedLoansInquiredAbout	1900000	usd
CY2022Q4	mho	Total Of Guaranteed Loans Inquired About TotalOfGuaranteedLoansInquiredAbout	2400000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	32902000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	29728000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5373000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4559000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	643000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	272000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5725000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5087000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	33193000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	29472000	usd
CY2023Q1	mho	Letters Of Credit And Bonds LettersOfCreditAndBonds	388800000	usd
CY2023Q1	mho	Outstanding Performance Bonds OutstandingPerformanceBonds	307100000	usd
CY2023Q1	mho	Performance Letters Of Credit Outstanding PerformanceLettersOfCreditOutstanding	69600000	usd
CY2023Q1	mho	Financial Letters Of Credit FinancialLettersOfCredit	4000000	usd
CY2023Q1	mho	Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Contracts OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionContracts	3500000	usd
CY2023Q1	mho	Financial Bonds FinancialBonds	4800000	usd
CY2023Q1	mho	Corporate Notes CorporateNotes	3300000	usd
CY2023Q1	us-gaap	Purchase Options Land PurchaseOptionsLand	824600000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1200000	usd
CY2023Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	1690000000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q1	mho	Letters Of Credit Outstanding Under Credit Facility LettersOfCreditOutstandingUnderCreditFacility	73600000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	576400000	usd
CY2023Q1	mho	Maximum Borrowing Availability Under All Credit Lines MaximumBorrowingAvailabilityUnderAllCreditLines	290000000	usd
CY2022Q4	mho	Maximum Borrowing Availability Under All Credit Lines MaximumBorrowingAvailabilityUnderAllCreditLines	390000000	usd
CY2023Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	223600000	usd
CY2022Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	245700000	usd
CY2023Q1	us-gaap	Equity Restrictions EquityRestrictions	708200000	usd
CY2022Q4	us-gaap	Equity Restrictions EquityRestrictions	661700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	103066000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	91839000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27602000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28424000	shares
CY2023Q1	mho	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	378000	shares
CY2022Q1	mho	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	336000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	325000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	312000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28305000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29072000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.73
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.23
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.64
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.16
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	266000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	434000	shares
CY2023Q1	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32900000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30400000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242	rate
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.249	rate
CY2023Q1	us-gaap	Revenues Revenues	1000530000	usd
CY2022Q1	us-gaap	Revenues Revenues	860811000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	134586000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	122905000	usd
CY2023Q1	mho	Interest Income Net Of Interest Expense InterestIncomeNetOfInterestExpense	1389000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	671000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	135982000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	122250000	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	58910000	usd
CY2023Q1	mho	Inventory Segments InventorySegments	2598499000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	49031000	usd
CY2023Q1	mho	Other Combined Assets OtherCombinedAssets	1055930000	usd
CY2023Q1	us-gaap	Assets Assets	3762370000	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	55739000	usd
CY2022Q4	mho	Inventory Segments InventorySegments	2772863000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	51554000	usd
CY2022Q4	mho	Other Combined Assets OtherCombinedAssets	834767000	usd
CY2022Q4	us-gaap	Assets Assets	3714923000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
CY2022Q1	mho	Stock Repurchase Program Authorized Amount Increasedecrease StockRepurchaseProgramAuthorizedAmountIncreasedecrease	100000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	93100000	usd
CY2023Q1	us-gaap	Revenues Revenues	1000530000	usd
CY2022Q1	us-gaap	Revenues Revenues	860811000	usd
CY2023Q1	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	4200000	usd
CY2022Q1	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	8200000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4217436	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1338412	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	487500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	58.73
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	24.67
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2000000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1800000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	23300000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2023Q1	mho	Percentageweightof Ps Usrelatedtoperformancecondition PercentageweightofPSUsrelatedtoperformancecondition	0.80	rate
CY2023Q1	mho	Percentageweightof Ps Usrelatedtomarketcondition PercentageweightofPSUsrelatedtomarketcondition	0.20	rate

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
mho-20230331_cal.xml	Edgar Link	unprocessable
0000799292-23-000048-index-headers.html	Edgar Link	pending
0000799292-23-000048-index.html	Edgar Link	pending
0000799292-23-000048.txt	Edgar Link	pending
0000799292-23-000048-xbrl.zip	Edgar Link	pending
exhibit22guarantors3-31x20.htm	Edgar Link	pending
exhibit311ceocertification.htm	Edgar Link	pending
exhibit312cfocertification.htm	Edgar Link	pending
exhibit321ceocertification.htm	Edgar Link	pending
exhibit322cfocertification.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mho-20230331.htm	Edgar Link	pending
mho-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
mho-20230331_lab.xml	Edgar Link	unprocessable
mho-20230331_pre.xml	Edgar Link	unprocessable
mho-20230331_htm.xml	Edgar Link	completed
mho-20230331_def.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MHO
M/I HOMES, INC. Stock $mho

2023 Q2 Form 10-Q Financial Statement

#000079929223000048 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHO M/I HOMES, INC. Stock $mho

2023 Q2 Form 10-Q Financial Statement

#000079929223000048 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHO
M/I HOMES, INC. Stock $mho